Abstract Aim-To investigate observer variation in the diagnosis of thin cutaneous malignant melanoma and related lesions in a nationwide sample of histopathologists in the UK. Methods-Out of a random sample of 195 pathologists, 148 (76%) participated in two circulations, the first with 20 slides and the second with 25 slides. The results were compared with those for the Cancer Research Campaign (CRC) Melanoma Pathology Panel, consisting of seven histopathologists and one dermatopathologist, which had developed and evaluated diagnostic criteria. Results-In the first circulation, when no standardised diagnostic criteria were used, a fair level of agreement was achieved for an overall diagnosis using the categories benign naevi with no atypia, benign naevi with atypia and melanoma (Kappa = 0.45). This was low compared with the agreement of the panel who used agreed criteria (Kappa = 0.75). Moreover, participants in the nationwide survey were more likely to diagnose melanoma and less likely to diagnose benign naevi without atypia than the panel. In the second circulation, when diagnostic criteria and diagrams were used, there was a higher level of agreement for overall diagnosis using the categories benign, melanocytic intraepidermal neoplasia (MIN) with or without microinvasion and melanoma with vertical growth phase, and was the same as that achieved by the panel using the same criteria (Kappa = 0.68). Conclusions-As the incidence rate ofthin melanomas has been increasing in the UK, it is important that standardised diagnostic criteria are used to ensure accurate reporting of incidence and correct management of patients. The use of MIN and the vertical growth phase seemed to be generally acceptable.
In several countries, there has been a notable increase in the incidence rate of cutaneous malignant melanoma and a shift towards diagnosis of lesions with a thin Breslow thickness.'
These thin or borderline lesions are disproportionately difficult to diagnose accurately and consistently. This has important implications at the individual level for patient management and at a nationwide level for the monitoring of trends in incidence of the disease. In 1991, the Cancer Research Campaign (CRC) Melanoma Pathology Panel was set up to investigate observer variation in the diagnosis of melanoma and to develop criteria to improve the differentiation of thin melanomas from melanocytic lesions showing severe dysplasia. 4 The panel included a histopathologist from each of the seven study areas associated with the CRC "Mole Watcher" health education programme5 and a dermatopathologist (NS) with a major interest in melanoma. They studied 96 randomly selected lesions from the study areas and found that overall observer variation was reduced with use of diagnostic criteria developed by the panel. Nevertheless, there remained poor concordance in distinguishing benign lesions with atypia from melanoma in situ lesions. These lesions represent a presumed progression and as their clinical management is the same,6 the panel recommended that both lesions could be termed melanocytic intraepidermal neoplasia (MIN). Melanomas with a vertical growth phase, based on the definitions of Clark et al,7 would remain the type of melanoma requiring more active treatment and follow up. As in most other studies of observer variation of melanoma diagnosis,8-' the number of histopathologists involved was small and included those with a special interest in melanoma. Therefore, the panel surveyed histopathologists in the UK to study observer variation in the differential diagnosis of thin melanomas, and to test the acceptability and the effect of diagnostic criteria for MIN on observer variation. nationwide sample, but the study was conducted using a difficult set of borderline lesions. A higher level of agreement could be expected with a routine case mix seen by most pathologists. The use of MIN merits further evaluation on a larger sample of lesions. As indicated by others,4 16 there is clearly a need for the use of standardised criteria to reduce observer variability in the diagnosis of thin melanomas. This is important for the monitoring of trends in incidence of melanoma and patient management.
